NPM1 and acute myeloid leukemia: In contrast, Sakaguchi’s group analyzed 147 patients with FLT3-ITD gene mutation-positive AML, stratifying them, according to ELN indications, into high and low AR, depending on the presence or absence of the NPM1 mutation.